The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone.
Wu
Peiwen
P
Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, China.
Yang
Liyong
L
Shen
Ximei
X
D000818:Animals; D045744:Cell Line, Tumor; D005230:Fatty Acids, Nonesterified / Q000378:metabolism / Q000633:toxicity*; D055785:Gene Knockdown Techniques; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000187:drug effects* / Q000378:metabolism*; D051379:Mice; D000077205:Pioglitazone; D010957:Plasmids / Q000235:genetics; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000378:metabolism*; D045162:Thiazolidinediones / Q000494:pharmacology
D005230:Fatty Acids, Nonesterified; C473036:Ffar1 protein, mouse; D007004:Hypoglycemic Agents; D007328:Insulin; D043562:Receptors, G-Protein-Coupled; D045162:Thiazolidinediones; D005947:Glucose; D000077205:Pioglitazone